top of page

HEALTH

PUBLIC HEALTH, BIOTECH AND MEDICINE
Bring Health Equality and Affordable Medication to Everyone
3.png
6.png
10.png

Kingdom Medical Health and Wellness Limited 

An Integrated Portfolio of Medication and Wellness for Both Developed and Developing Worlds

Kingdom Medical Health and Wellness Limited is a prominent investment company that is at the forefront of revolutionizing the healthcare industry. Our strategic approach involves investing in cutting-edge biotech, medical science, and other related intellectual properties to drive innovation and advancement in medical technologies. At the same time, we recognize the pressing need for accessible and affordable healthcare solutions, which is why we invest in the production of high-quality, cost-effective medicines that cater to both high-end markets and underserved populations.

In addition to our focus on intellectual property and medicine production, we actively invest in hospital construction, management, and operation. By building and managing state-of-the-art healthcare facilities, we ensure that patients have access to world-class medical services and infrastructure. Our commitment extends to the development of emergency medical services and the supply of crucial medicines in developing regions, where access to quality healthcare is limited. Through these initiatives, we aim to bridge the healthcare gap and improve health outcomes for vulnerable communities.

At Kingdom Medical Health and Wellness Limited, we understand the importance of collaboration and strategic partnerships. We actively seek opportunities to collaborate with leading research institutions, medical professionals, and industry experts to foster innovation and leverage the latest advancements in medical science. This collaborative approach enables us to stay at the forefront of breakthrough discoveries and contribute to the development of medical technologies.

As part of our commitment to sustainability and social responsibility, we are dedicated to adhering to stringent ethical standards, promoting environmental sustainability, and ensuring the well-being of our employees, partners, and the communities in which we operate in. By incorporating these principles into our business strategies, we aim to create a positive impact on the society while delivering sustainable financial returns to our investors. Kingdom Medical Health and Wellness Limited is positioned as a leader in transforming the healthcare landscape. With our strategic investments in biotech, medical science, medicine production, hospital infrastructure, and emergency medical services, we strive to elevate global healthcare standards and improve access to quality healthcare for all. Through innovation, collaboration, and a commitment to sustainability, we aim to make a lasting positive impact on the well-being of individuals and communities worldwide.
 

Business Activities

At Kingdom Medical Health and Wellness Limited, we are dedicated to advancing the field of healthcare through strategic investments in biotechnology, vaccine development, and medical science intellectual property research and development (R&D). We recognize the transformative potential of breakthrough discoveries in these areas and actively invest in cutting-edge R&D projects. By fostering innovation and supporting the development of novel treatments and therapies, we aim to improve patient outcomes and address unmet medical needs on a global scale.

Key Subsidiaries & Ventures

Kingdom Genesis Medical Group

Biotechnology Research and Development

Kingdom Genesis Medical Group promotes health and longevity in today’s health-conscious society. We identify, enhance, and offer innovative, cost-effective healthcare solutions for the world’s aging population and life-affecting illnesses. One of the approaches we take involves exploring potential solutions by integrating biotechnology and medical technologies in areas such as lifestyle, anti-aging, regeneration, critical illnesses, and more. Some of our resources include R&D laboratory, which supports innovation and product validation; diagnostic platform and manufacturing facility, which allow us to provide efficient and comprehensive health monitoring, stem-cell therapies, and personalized treatments; VivaLife, our bioinformatic platform that integrates personal health data for prediction, prevention, and population-based healthcare solutions. On top of these, we also provide a diverse range of validated supplements for daily health and longevity.

pexels-tima-miroshnichenko-9574572.jpg
220776-Arista_logo.jpeg.318x213.jpeg

ARISTA Biotech Pte. Ltd.

COVID-19 Response, Vaccines and Personal Protection Equipment
CUHK.jpg
CUHK.jpg

Kingdom Investment Corporation Limited partnered with ARISTA Biotech Pte. Ltd. to perform businesses related to COVID-19 response such as sourcing vaccines and PPEs. ARISTA Biotech Pte. Ltd. is a company that focuses on creating access to innovative and affordable products and technologies, strategic advice, and data analytics in the management of the COVID-19 pandemic. In collaboration with laboratories, manufacturers, and R&D centers in the United States, United Kingdom, and Asia, the company currently offers an array of approved, validated, and affordable COVID-19 test products. The company has an on-the-ground team to ensure quality control, while its expanding global sales network furthers the reach of these crucial testing solutions.

pexels-artem-podrez-5878504.jpg

Kingdom Elevatus Health Holding, Inc.

Pharmaceutical Manufacturer, Future Global Leader in Liposomal Technology

Kingdom Elevatus Health Holding, Inc. is a US-based pharmaceutical manufacturer specializing in liposome and nanoparticle drug delivery platforms. Our short-term goal is to focus on the critical shortage problem of generic pharmaceuticals, such as liposome and sterile-fill products, which have high entry barriers. By developing innovative drug delivery platforms, our medium to long-term goal is to become a world leader in liposomal pharmaceuticals, focusing on its application in inflammation and oncology. Further, we plan to invest in generic drug manufacturing infrastructure and expertise to manufacture and deliver our own pharmaceuticals directly to consumers, targeting the most commonly prescribed and most costly generics.

nastya-dulhiier-x2cooe_MaG8-unsplash.jpg
11129.jpg

KICL Group Domain Experts for Health

bottom of page